CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Intermittent claudication (peripheral artery disease)

Comorbid ConditionsDisease / conditionriskpartially modifiable
18
evidence score

Also known as: Intermittent claudication, intermittent claudication

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 3meta-analyses: 0trials: 15genetic: 0MR bonus:

References (1)

0 meta-analyses / systematic reviews

Clinical trials (152)

showing top 60
NCTTitleStatusTypeInterventions
NCT06686121IMProving Mobility After revasCularizaTion in Peripheral Artery Disease: The IMPACT PAD TrialRECRUITINGINTERVENTIONALHome Based Exercise, Nitrate Rich Beetroot Juice, Attention Control
NCT06410521Personalisation of Non-surgical Treatment in Peripheral Arterial Disease Using a Multicomponent Exercise ApproachRECRUITINGINTERVENTIONALExercise, Usual care
NCT06657976Response to Exercise and Nitric Oxide in Peripheral Artery Disease: The RESIST PAD TrialRECRUITINGINTERVENTIONALSupervised Treadmill Exercise, Attention Control, Nitrate-Rich Beetroot Juice + supervised exercise therapy
NCT06529185Effect of Breather on Ventilatory and Vascular Function in Chronic Obstructive Pulmonary Disease Patients With Intermittent Claudication.RECRUITINGINTERVENTIONALThe BREATHER, pharmacological treatment
NCT05457738Home-based Exercice Therapy for Patients With Intermittent Claudication Using a New Smartphone Application : a Monocentric Randomized StudyRECRUITINGINTERVENTIONALE-REVA® app, No E-REVA® app
NCT07588295Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease: the LAST-COP StudyRECRUITINGINTERVENTIONALOptical Coherence Tomography assessment
NCT06114732Motivating Physical Activity With Behavioural interVention and Electrical Stimulation Remotely in People With Intermittent Claudication (MAvERIC): a Feasibility Randomised Controlled TrialRECRUITINGINTERVENTIONALWalking exercise behaviour change intervention + TENS
NCT06299956Supervised Exercise-based Rehabilitation for People With Intermittent Claudication - Study Protocol for a Danish Implementation Process (StRiDE).RECRUITINGINTERVENTIONALSupervised exercise therapy
NCT05132439Metformin BenefIts Lower Extremities With Intermittent Claudication (MOBILE_IC)RECRUITINGINTERVENTIONALMetformin ER, placebo
NCT06827691Heat Therapy for People with Peripheral Artery Disease: a Randomised Wait-List Controlled Feasibility Trial.NOT YET RECRUITINGINTERVENTIONALHeat Therapy Intervention
NCT06186505Heat Therapy for Peripheral Arterial Disease (HEATPAD)WITHDRAWNINTERVENTIONALAirGlove
NCT06424548A Randomized, Open-label, Investigator-initiated, Pilot Clinical Trial Comparing the Improvement for Ankle Brachial Index and Safety of Sarpogrelate and Clopidogrel in Stroke Patients Accompanying Lower Extremity Vascular Atherosclerosis With Decrease of Ankle Brachial Index and Intermittent Claudication.NOT YET RECRUITINGINTERVENTIONALAdministration of Sarpogrelate, Traditional administration of Clopidogrel
NCT06176898The Effect of Neurostimulation on Patient Relevant Outcomes in Patients With Intermittent Claudication: a Pilot StudyUNKNOWNINTERVENTIONALNeurostimulating device
NCT06570564Upper Versus Lower Limb Exercises on Intermittent Claudication in Diabetic PatientsCOMPLETEDINTERVENTIONALThe arm crank ergometer, bicycle ergometer, treadmill
NCT05618691A Double-blinded, Randomized, Placebo-controlled Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC)WITHDRAWNINTERVENTIONALGFH312, Placebo
NCT05232474Implementation and Evaluation of a Guideline-based Clinical Decision Support System (KomPas+) Used by Therapists and Patients in the Treatment of Intermittent Claudication: a Cluster Randomized Trial With a Parallel Process EvaluationCOMPLETEDINTERVENTIONALKomPas+, KomPas
NCT05400395A Prospective, Randomized, Placebo-controlled, Double-blinded, Multi-center, Phase IV, Exploratory Clinical Trial to Demonstrate the Effect of Improving the Walking Distance by GNX80 in Patients With Intermittent ClaudicationUNKNOWNINTERVENTIONALGNX80, Placebo
NCT05466734An Open-Label, Randomized, Two-Treatment, Two-Sequence, Four-Period, Fully Replicated Crossover Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy VolunteersCOMPLETEDINTERVENTIONALCilostazol Tablet 100 mg, PMR Tablet 135 mg
NCT05611021Acute Responses to Arm-Crank Exercise on Cardiovascular Function of Patients With Peripheral Artery Disease: Randomized Crossover StudyCOMPLETEDINTERVENTIONALExercise
NCT05260567A Multimodal Tele-health Behavioural Intervention in Patients With Peripheral Arterial Disease From Low Socio-economic Areas: a Feasibility and Pilot Randomized Controlled Trial With Embedded Process EvaluationCOMPLETEDINTERVENTIONALExercise and Lifestyle Change
NCT03686306VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication. A Phase III, National, Multicentre, Prospective, Randomised, Double-blind, Placebo-Controlled Trial.ACTIVE NOT RECRUITINGINTERVENTIONALSildenafil, Placebo
NCT05029739An Interactive E-health Intervention to Promote Walking Capacity and Life-style Changes in Peripheral Artery Disease (iPAD)UNKNOWNINTERVENTIONALA PAD-specific smartphone application (e-intervention) developed for patients with Peripheral Artery Disease
NCT04586725The Effect of Encouragement on Six Minute Walk Test Performance in Patients With Intermittent ClaudicationUNKNOWNINTERVENTIONALEncouragement a one minute intervals, Encouragement a two minute intervals
NCT04390282Secondary Prevention and Application-based Lifestyle Support for Patients With Intermittent ClaudicationCOMPLETEDINTERVENTIONALApplication-based support system
NCT04800692The Effects of ATLAS (Arginine Tetrahydrobiopterin L-Ascorbate) Therapy on Nitric Oxide Bioavailability and Pain-free Walking in Patients With Intermittent ClaudicationACTIVE NOT RECRUITINGINTERVENTIONALTetrahydrobiopterin 10 mg/kg, Tetrahydrobiopterin 20 mg/kg, L-Ascorbate
NCT04853719A Prospective, Randomized, Open-label, Multicenter Study Comparing Rivaroxaban 2.5 mg Twice Daily Associated With Aspirin 100 mg Once Daily Versus Aspirin 100 mg Once Daily in Patients With Peripheral Arterial Disease and Limiting Intermittent Claudication. (The COMPASS CLAUDICATION Trial).COMPLETEDINTERVENTIONALRivaroxaban 2.5 Mg Oral Tablet
NCT04572737Personalised Activity Plan for BREAKing UP Sitting Time in Patients With Peripheral Arterial Disease and Intermittent Claudication (The BREAK UP Study)UNKNOWNINTERVENTIONALActivity plan to break up sitting time
NCT00424866A Phase 1, Open Label, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Peripheral Arterial Disease Patients With Intermittent ClaudicationUNKNOWNINTERVENTIONALFGF-1, Placebo
NCT06046196A Randomized, Multicenter, Open-label, Parallel, Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients Having Intermittent Claudication Among Chronic Artery Occlusive DiseaseCOMPLETEDINTERVENTIONALSarpogrelate SR, Sarpogrelate
NCT04302571Effects of Home-based Combined Aerobic and Resistance Training on Walking Capacity, Circulating Endothelial Progenitor Cells AND Endothelial Function in Patients With Intermittent ClaudicationUNKNOWNINTERVENTIONALcombined aerobic and resistance physical activity, sham exercise
NCT04168021Remote Ischemic Conditioning of the Human Brain in Dementia Patients (RICBDE): Protocol for a Crossover Non-pharmaceutical Intervention StudyUNKNOWNINTERVENTIONALLeg ischemia
NCT03837639Effects of Arm-crank Exercise Training on Cardiovascular Function of Patients With Peripheral Artery Disease: a Randomized Controlled TrialUNKNOWNINTERVENTIONALArm ergometer, Treadmill ergometer, Control group
NCT03864666An Open-Label, Randomized, Two-Treatment, Two-Sequence, Four-Period, Fully Replicated Crossover Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy VolunteersCOMPLETEDINTERVENTIONALCilostazol 100 mg, PMR 200 mg
NCT03640676Intermittent Negative Pressure to Improve Blood Flow in Patients With Peripheral Artery Disease: Effects After Long-term TreatmentCOMPLETEDINTERVENTIONALFlowOx
NCT02678403Efficacy of Transcutaneous Electrical Nerve Stimulation in the Improvement of Walking Distance in Patients With Peripheral Artery Disease With Intermittent ClaudicationTERMINATEDINTERVENTIONALTranscutaneous electrical nerve stimulation (TENS), SHAM Transcutaneous electrical nerve stimulation (TENS)
NCT03564080An Investigation Into the Feasibility of Incorporating an Exercise Rehabilitation Programme for People With Peripheral Artery Disease Into an Already Established Cardiac Rehabilitation Service.COMPLETEDINTERVENTIONALCombined - PAD and CAD
NCT04042311High Intensity Interval Training In pATiEnts With Intermittent Claudication (INITIATE): a Proof-of-concept Prospective Cohort Study to Assess Acceptability, Feasibility and Potential Clinical EfficacyCOMPLETEDINTERVENTIONALHigh-intensity interval training
NCT03511157Walking Capacity of Patients With Claudication in Lower Extremities Following Ischemic PreconditioningCOMPLETEDINTERVENTIONALIschemic Preconditioning, Control Group
NCT03547817Intermittent Negative Pressure to Improve Blood Flow in Patients With Peripheral Artery Disease. An Experimental Study to Investigate the Optimal Pulse Pressure Regime to Improve Blood Flow.COMPLETEDINTERVENTIONALIntermittent negative pressure device
NCT03480321An Open-Label, Randomized, Three-Treatment, Three-Way Crossover Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy VolunteersCOMPLETEDINTERVENTIONALCilostazol 100 mg, PMR 150 mg, PMR 200 mg
NCT03446027A Multicenter Randomised Controlled Study: Does Neuromuscular Electrical Stimulation Improve the Absolute Walking Distance in Patients With Intermittent Claudication (NESIC) Compared to Best Available Treatment?COMPLETEDINTERVENTIONALNMES
NCT03730623Cross-sectoral Rehabilitation for Patients With Intermittent Claudication: Effects and Patient Experience - The CIPIC-Rehab Study (Cross-sectoral Intervention for Patients With Intermittent Claudication)UNKNOWNINTERVENTIONALSupervised exercise training
NCT03238222A Brief Physiotherapist-led Behaviour Change Intervention to Facilitate Walking in Older People With Peripheral Arterial Disease: a Randomised Controlled TrialUNKNOWNINTERVENTIONALMOSAIC
NCT04043546Observational Feasability Study of Home-based Training With Therabands in PAD-patients - Addressing the Uncertainty of Acceptance, Satisfaction and Usability of a Home-based, Tele-monitored Program Combining Aerobic and Resistance Components in PAD-patients.COMPLETEDINTERVENTIONALaerobic+resistance exercise training program
NCT03194776A Patient and Investigator-blinded, Randomized, Placebo Controlled Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent ClaudicationCOMPLETEDINTERVENTIONALLLG783, Placebo
NCT03271710A Single-Arm, Multicenter Study for the Lower Extremities Using the Vanguard IEP Peripheral Balloon Angioplasty System With Integrated Embolic ProtectionCOMPLETEDINTERVENTIONALperipheral balloon angioplasty
NCT03204825Pain Management and Patient Education for Physical Activity in Intermittent Claudication (PrEPAID): Feasibility Randomised Controlled TrialCOMPLETEDINTERVENTIONALActive TENS, Patient-Centred Education, Placebo TENS
NCT02924857A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch™ Paclitaxel Coated Balloon Catheter, in Above the Knee LesionsACTIVE NOT RECRUITINGINTERVENTIONALChocolate Touch, Lutonix Drug Coated Balloon
NCT02993874Effect of Creatine Supplementation Associated to Clinical Treatment of the Functional Capacity of Patients With Intermittent Claudication.UNKNOWNINTERVENTIONALCreatine, Placebo
NCT03590769Arterial Imaging of Inflammation and Resolution After Endovascular SurgeryCOMPLETEDINTERVENTIONAL18F-FDG
NCT06886620A Phase III Prospective, Randomized, Double Blind, Active Controlled, Multicenter, Parallel Group Study to Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent ClaudicationTERMINATEDINTERVENTIONALCilostazol 200 mg, Cilostazol 100 mg
NCT02380794Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) CapsuleCOMPLETEDINTERVENTIONALDanshen Gegen Capsule, Placebo
NCT02607046Post-revascularization Rehabilitation to Improve Function in Veterans With PADCOMPLETEDINTERVENTIONALExercise training, NMES
NCT02373462Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)TERMINATEDINTERVENTIONALOlmesartan, other anti-hypertensive drug
NCT02642276Influence of Different Types of Exercise Training on Selected Cardiovascular Parameters in Individuals With Peripheral Arterial DiseaseCOMPLETEDINTERVENTIONALExercise training
NCT02652078Extracorporeal Shockwave Therapy in the Treatment of Intermittent Claudication Symptoms in Peripheral Vascular DiseaseACTIVE NOT RECRUITINGINTERVENTIONALExtracorporeal shockwave therapy
NCT02641418Optimising the Efficacy, Patient Perception and Uptake of an Exercise Programme in People in Intermittent ClaudicationCOMPLETEDINTERVENTIONALSupervised exercise programme
NCT02429310Adjuvant Benefit of Neuromuscular Electrical Stimulation to Supervised Exercise in Patients With Intermittent ClaudicationCOMPLETEDINTERVENTIONALRevitive IX
NCT02436200Neuromuscular Electrical Stimulation in Patients With Intermittent ClaudicationCOMPLETEDINTERVENTIONALNeuromuscular Electrical Stimulation
NCT02310256A Randomized Clinical Trial on the Effects of Home-based Five Plus Exercise TrainingCOMPLETEDINTERVENTIONALFive plus exercise training

Genetic associations (0)

None linked.